Berry Genomics Co.,Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1,151.42 million compared to CNY 1,368.01 million a year ago. Net loss was CNY 427.2 million compared to CNY 248.93 million a year ago.

Basic loss per share from continuing operations was CNY 1.21 compared to CNY 0.81 a year ago. Diluted loss per share from continuing operations was CNY 1.21 compared to CNY 0.81 a year ago.